Fig. 1From: Immune checkpoint inhibitors and response analysis: a tough challenge. A case reportMetastatic localizations in the liver (VII and VIII segment) in the CT-scan of September 2014 (on the left), before treatment with antiPD-L1, and November 2014, after 6 weeks of treatment with antiPD-L1 (on the right) (H&E, ×20). The arrow shows the metastatic localization where the biopsy was performedBack to article page